The 136th meeting of the Association of Clinical Scientists hosted by the University of Arkansas for Medical Sciences, the department was well represented by our current residents.  Their presentations included:

  • Maren Fuller, M.D. Undifferentiated Embryonal Sarcoma of the Liver:
    Morphoproteomics Confirms EZH2 and Sirt1 Pathways with Pathogenetic and Therapeutic Implications.  (Dr. Fuller, currently a senior resident at Methodist, served a pediatric pathology rotation with Dr. Tatevian during this past year).
  • Suvra Roy, M.D. Morphoproteomics Identifies the EZH2 Sirt1 Pathways As Potential Blocks to differentiation in Sinonasal Undifferentiated Carcinoma (SNUC) and Provides Therapeutic Options.
  • Elizabeth Jacobi, M.D. Sunitinib-Associated Sarcomatoid Transformation in Metastatic Renal Cell Carcinoma: A Morphoproteomic Analysis.
  • Jennifer Dierksen, M.D. Incidence and Clinical Association of Peptic Duodenitis in a Pediatric Population.
  • Annelise Velez-Perez, M.D. Mechanism of Metformin INduced Cell Death in MOLT4 Acute Leukemia Cells.
  • Suhair Al Salihi, M.D. Morphoproteomics Identifies the Etiopathogenetic Correlates of HHV-8-Associated Kaposi’s Sarcoma and Provides Pathways with Therapeutic Options: A Case Study.

    Dr. Hunter, Dr. Tatevian and Dr. Brown, collectively had the privilege of hearing their presentations and witnessing their response to questions from the audience of clinical scientist in attendance. The Residents representated themselves, the department, the residency program and UTHealth in such a consistently articulate, logical and scientific manner.Please congratulate the residents on their tremendous efforts.